1. Home
  2. Analysis
  3. Pepcid
  4. Exondys-51

Pepcid and Exondys 51 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid (famotidine) and Exondys 51 (eteplirsen). Common drug interactions include poor venous access among males.

The phase IV clinical study analyzes what interactions people have when they take Pepcid and Exondys 51. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

What is Exondys 51?

Exondys 51 has active ingredients of eteplirsen. eHealthMe is studying from 1,598 Exondys 51 users. Check the latest studies of Exondys 51.

On Jul, 29, 2026

33 people who take Pepcid and Exondys 51 together, and have interactions are studied.

Pepcid and Exondys 51 drug interactions.

What are the common drug interactions of Pepcid and Exondys 51, by gender? *:

female:

n/a

male:

  1. Poor venous access
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Influenza like illness
  4. Pyrexia (fever)
  5. Respiratory syncytial virus infection (viral disease of respiratory system)
  6. Anxiety
  7. Delusion (a false belief or opinion)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Dyspnoea (difficult or laboured respiration)
  10. Headache (pain in head)

What are the common drug interactions of Pepcid and Exondys 51, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Poor venous access
  2. Infusion site scar
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Dehydration (dryness resulting from the removal of water)
  5. Ear infection
  6. Fall
  7. Influenza like illness
  8. Anxiety
  9. Delusion (a false belief or opinion)
  10. Dysphagia (a condition in which swallowing is difficult or painful)

20-29:

  1. Dry mouth
  2. Fatigue (feeling of tiredness)
  3. Respiratory distress (difficulty in breathing)
  4. Respiratory tract infection
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Neuralgia (pain in one or more nerves)
  7. Dehydration (dryness resulting from the removal of water)
  8. Dyspnoea (difficult or laboured respiration)
  9. Hypokalaemia (low potassium)
  10. Hypoxia (low oxygen in tissues)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Constipation: 5 people, 15.15%
  2. Rickets (softening of bones): 4 people, 12.12%
  3. Migraine (headache): 3 people, 9.09%
  4. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid and Exondys 51?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pepcid and Exondys 51:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Exondys 51:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exondys 51 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and eteplirsen (the active ingredients of Pepcid and Exondys 51, respectively), and Pepcid and Exondys 51 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.